DOCEBO INC (DCBO) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:DCBO • CA25609L1058

18.85 USD
-0.7 (-3.58%)
Last: Feb 11, 2026, 08:16 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

DCBO gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 277 industry peers in the Software industry. DCBO has an average financial health and profitability rating. An interesting combination arises when we look at growth and value: DCBO is growing strongly while it also seems undervalued. This makes DCBO very considerable for value and growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year DCBO was profitable.
  • In the past year DCBO had a positive cash flow from operations.
  • In multiple years DCBO reported negative net income over the last 5 years.
  • DCBO had a positive operating cash flow in 4 of the past 5 years.
DCBO Yearly Net Income VS EBIT VS OCF VS FCFDCBO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

  • With an excellent Return On Assets value of 13.03%, DCBO belongs to the best of the industry, outperforming 90.61% of the companies in the same industry.
  • DCBO has a Return On Equity of 49.89%. This is amongst the best in the industry. DCBO outperforms 96.39% of its industry peers.
  • DCBO's Return On Invested Capital of 29.21% is amongst the best of the industry. DCBO outperforms 96.75% of its industry peers.
Industry RankSector Rank
ROA 13.03%
ROE 49.89%
ROIC 29.21%
ROA(3y)6.1%
ROA(5y)2.04%
ROE(3y)18.51%
ROE(5y)8.92%
ROIC(3y)N/A
ROIC(5y)N/A
DCBO Yearly ROA, ROE, ROICDCBO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 150

1.3 Margins

  • Looking at the Profit Margin, with a value of 9.54%, DCBO is in the better half of the industry, outperforming 69.68% of the companies in the same industry.
  • Looking at the Operating Margin, with a value of 10.98%, DCBO is in the better half of the industry, outperforming 76.90% of the companies in the same industry.
  • DCBO's Gross Margin of 80.80% is amongst the best of the industry. DCBO outperforms 83.03% of its industry peers.
  • DCBO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.98%
PM (TTM) 9.54%
GM 80.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.38%
GM growth 5Y0.22%
DCBO Yearly Profit, Operating, Gross MarginsDCBO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so DCBO is creating value.
  • DCBO has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, DCBO has more shares outstanding
  • Compared to 1 year ago, DCBO has an improved debt to assets ratio.
DCBO Yearly Shares OutstandingDCBO Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DCBO Yearly Total Debt VS Total AssetsDCBO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • DCBO has an Altman-Z score of 2.81. This is not the best score and indicates that DCBO is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of DCBO (2.81) is better than 64.26% of its industry peers.
  • The Debt to FCF ratio of DCBO is 0.10, which is an excellent value as it means it would take DCBO, only 0.10 years of fcf income to pay off all of its debts.
  • DCBO has a better Debt to FCF ratio (0.10) than 80.14% of its industry peers.
  • DCBO has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of DCBO (0.05) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.1
Altman-Z 2.81
ROIC/WACC2.83
WACC10.31%
DCBO Yearly LT Debt VS Equity VS FCFDCBO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

  • DCBO has a Current Ratio of 1.13. This is a normal value and indicates that DCBO is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.13, DCBO is not doing good in the industry: 69.31% of the companies in the same industry are doing better.
  • A Quick Ratio of 1.13 indicates that DCBO should not have too much problems paying its short term obligations.
  • DCBO's Quick ratio of 1.13 is on the low side compared to the rest of the industry. DCBO is outperformed by 67.87% of its industry peers.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 1.13
DCBO Yearly Current Assets VS Current LiabilitesDCBO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 120.69% over the past year.
  • Looking at the last year, DCBO shows a quite strong growth in Revenue. The Revenue has grown by 13.16% in the last year.
  • The Revenue has been growing by 39.25% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)120.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%112.5%
Revenue 1Y (TTM)13.16%
Revenue growth 3Y27.67%
Revenue growth 5Y39.25%
Sales Q2Q%11.16%

3.2 Future

  • Based on estimates for the next years, DCBO will show a very strong growth in Earnings Per Share. The EPS will grow by 27.76% on average per year.
  • Based on estimates for the next years, DCBO will show a very strong growth in Revenue. The Revenue will grow by 24.94% on average per year.
EPS Next Y52.01%
EPS Next 2Y33.13%
EPS Next 3Y24.83%
EPS Next 5Y27.76%
Revenue Next Year11.86%
Revenue Next 2Y9.62%
Revenue Next 3Y9.58%
Revenue Next 5Y24.94%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
DCBO Yearly Revenue VS EstimatesDCBO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
DCBO Yearly EPS VS EstimatesDCBO Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • DCBO is valuated correctly with a Price/Earnings ratio of 14.73.
  • Compared to the rest of the industry, the Price/Earnings ratio of DCBO indicates a rather cheap valuation: DCBO is cheaper than 80.14% of the companies listed in the same industry.
  • DCBO's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.18.
  • A Price/Forward Earnings ratio of 12.37 indicates a correct valuation of DCBO.
  • DCBO's Price/Forward Earnings ratio is rather cheap when compared to the industry. DCBO is cheaper than 81.59% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of DCBO to the average of the S&P500 Index (28.01), we can say DCBO is valued rather cheaply.
Industry RankSector Rank
PE 14.73
Fwd PE 12.37
DCBO Price Earnings VS Forward Price EarningsDCBO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, DCBO is valued a bit cheaper than the industry average as 77.98% of the companies are valued more expensively.
  • DCBO's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. DCBO is cheaper than 76.53% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.26
EV/EBITDA 16.35
DCBO Per share dataDCBO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • DCBO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of DCBO may justify a higher PE ratio.
  • DCBO's earnings are expected to grow with 24.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.28
PEG (5Y)N/A
EPS Next 2Y33.13%
EPS Next 3Y24.83%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • DCBO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DOCEBO INC

NASDAQ:DCBO (2/11/2026, 8:16:24 PM)

18.85

-0.7 (-3.58%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-07
Earnings (Next)02-27
Inst Owners35.28%
Inst Owner Change-0.79%
Ins Owners0.38%
Ins Owner ChangeN/A
Market Cap541.56M
Revenue(TTM)236.69M
Net Income(TTM)22.57M
Analysts80
Price Target25.75 (36.6%)
Short Float %1.66%
Short Ratio2.55
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.54%
Min EPS beat(2)1.01%
Max EPS beat(2)28.07%
EPS beat(4)4
Avg EPS beat(4)48.23%
Min EPS beat(4)1.01%
Max EPS beat(4)137.79%
EPS beat(8)7
Avg EPS beat(8)24.84%
EPS beat(12)10
Avg EPS beat(12)79.61%
EPS beat(16)13
Avg EPS beat(16)103.19%
Revenue beat(2)1
Avg Revenue beat(2)0.24%
Min Revenue beat(2)-0.86%
Max Revenue beat(2)1.34%
Revenue beat(4)1
Avg Revenue beat(4)-0.41%
Min Revenue beat(4)-1.61%
Max Revenue beat(4)1.34%
Revenue beat(8)2
Avg Revenue beat(8)-0.43%
Revenue beat(12)2
Avg Revenue beat(12)-0.67%
Revenue beat(16)2
Avg Revenue beat(16)-0.97%
PT rev (1m)-6.35%
PT rev (3m)-12.73%
EPS NQ rev (1m)1.84%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)10.3%
Revenue NQ rev (1m)0.56%
Revenue NQ rev (3m)1.97%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.58%
Valuation
Industry RankSector Rank
PE 14.73
Fwd PE 12.37
P/S 2.29
P/FCF 19.26
P/OCF 18.54
P/B 11.97
P/tB 18.35
EV/EBITDA 16.35
EPS(TTM)1.28
EY6.79%
EPS(NY)1.52
Fwd EY8.09%
FCF(TTM)0.98
FCFY5.19%
OCF(TTM)1.02
OCFY5.39%
SpS8.24
BVpS1.57
TBVpS1.03
PEG (NY)0.28
PEG (5Y)N/A
Graham Number6.73
Profitability
Industry RankSector Rank
ROA 13.03%
ROE 49.89%
ROCE 49.84%
ROIC 29.21%
ROICexc N/A
ROICexgc N/A
OM 10.98%
PM (TTM) 9.54%
GM 80.8%
FCFM 11.88%
ROA(3y)6.1%
ROA(5y)2.04%
ROE(3y)18.51%
ROE(5y)8.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.38%
GM growth 5Y0.22%
F-Score7
Asset Turnover1.37
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.1
Debt/EBITDA 0.07
Cap/Depr 33.69%
Cap/Sales 0.46%
Interest Coverage 250
Cash Conversion 99.87%
Profit Quality 124.57%
Current Ratio 1.13
Quick Ratio 1.13
Altman-Z 2.81
F-Score7
WACC10.31%
ROIC/WACC2.83
Cap/Depr(3y)34.45%
Cap/Depr(5y)55.59%
Cap/Sales(3y)0.56%
Cap/Sales(5y)1.02%
Profit Quality(3y)220.57%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)120.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%112.5%
EPS Next Y52.01%
EPS Next 2Y33.13%
EPS Next 3Y24.83%
EPS Next 5Y27.76%
Revenue 1Y (TTM)13.16%
Revenue growth 3Y27.67%
Revenue growth 5Y39.25%
Sales Q2Q%11.16%
Revenue Next Year11.86%
Revenue Next 2Y9.62%
Revenue Next 3Y9.58%
Revenue Next 5Y24.94%
EBIT growth 1Y52.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year131.07%
EBIT Next 3Y46.26%
EBIT Next 5Y33.26%
FCF growth 1Y153.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y150.06%
OCF growth 3YN/A
OCF growth 5YN/A

DOCEBO INC / DCBO FAQ

Can you provide the ChartMill fundamental rating for DOCEBO INC?

ChartMill assigns a fundamental rating of 6 / 10 to DCBO.


What is the valuation status of DOCEBO INC (DCBO) stock?

ChartMill assigns a valuation rating of 7 / 10 to DOCEBO INC (DCBO). This can be considered as Undervalued.


How profitable is DOCEBO INC (DCBO) stock?

DOCEBO INC (DCBO) has a profitability rating of 6 / 10.


How financially healthy is DOCEBO INC?

The financial health rating of DOCEBO INC (DCBO) is 6 / 10.